Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China · Delayed Price · Currency is CNY 15.43
-0.24 (-1.53%)
May 20, 2026, 11:29 AM CST
SHA:603858 Revenue
Shandong Buchang Pharmaceuticals had revenue of 2.58B CNY in the quarter ending March 31, 2026, a decrease of -7.39%. This brings the company's revenue in the last twelve months to 11.67B, up 4.65% year-over-year. In the year 2025, Shandong Buchang Pharmaceuticals had annual revenue of 11.88B with 7.90% growth.
Revenue (ttm)
11.67B
Revenue Growth
+4.65%
P/S Ratio
1.42
Revenue / Employee
1.52M
Employees
7,689
Market Cap
16.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.88B | 869.22M | 7.90% |
| Dec 31, 2024 | 11.01B | -2.24B | -16.91% |
| Dec 31, 2023 | 13.25B | -1.71B | -11.41% |
| Dec 31, 2022 | 14.95B | -811.43M | -5.15% |
| Dec 31, 2021 | 15.76B | -244.03M | -1.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition